[Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study].
Xu Q, Zhang W, Ma YX, He CN, Zhang LT, Abulitifu Y, Li Y, Wang N, Wang HL, Zhao YY, Gao X, Gao PG, Su XY, Li S, Liu YY, Guo F, Chen ZQ, Liu HL, Gao XQ, Fu JJ, Yu GY, Wang XZ, Wang JP, Zhang YP, Ji FP.
Xu Q, et al. Among authors: zhao yy.
Zhonghua Gan Zang Bing Za Zhi. 2021 Nov 20;29(11):1046-1052. doi: 10.3760/cma.j.cn501113-20201010-00548.
Zhonghua Gan Zang Bing Za Zhi. 2021.
PMID: 34933421
Chinese.